Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of GSK's 11PCV Vaccine in Healthy Adults
NCT00327522Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of 11-valent pneumococcal conjugate vaccine in pneumococcal disease, sponsored by GSK. Started Jun 2006; status: completed.
02
Drugs
11-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT00327522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00327522.